MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia

J Rheumatol. 2000 Sep;27(9):2193-7.

Abstract

Objective: We investigated the distribution of MICA triplet repeat polymorphism in a random population and in patients with seronegative spondyloarthritis from Sardinia compared to continental Italy.

Methods: We analyzed the distribution of MICA triplet repeat polymorphism in HLA-B*2709 [not associated with ankylosing spondylitis (AS)] and B*2705 (associated with AS) haplotypes, to verify whether the strong association of MICA-A4 with HLA-B27 reported in other populations is maintained in Sardinia, and compared the distribution of MICA-A alleles in HLA-B27 negative versus HLA-B27+ patients with AS.

Results: We found that the frequency of MICA-A4 triplet repeat allele in a random Sardinia population is higher (53.2%) than in other Caucasian populations (around 20%); this allele is strongly associated with both HLA-B*2709 and B*2705. No significant difference between HLA-B27+ patients with AS and healthy controls was found: the MICA-A4 allele was present in more than 90% of subjects. MICA-A4 was found in 16 out of 20 HLA-B27 negative Sardinian patients with AS, with a frequency (80%) more similar to that of the HLA-B27+ group of patients than that of controls.

Conclusion: The high frequency of MICA-A4 allele in HLA-B27 negative patients with AS from Sardinia, suggests the presence within the HLA region of a susceptibility factor other and certainly weaker than B27. This factor is likely to be more easily found by analyzing genetically homogeneous populations like the Sardinian, characterized by a small number of very frequent haplotypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HLA-B27 Antigen / genetics*
  • Histocompatibility Antigens Class I / genetics*
  • Humans
  • Italy
  • Microsatellite Repeats / genetics
  • Polymorphism, Genetic / genetics*
  • Spondylitis, Ankylosing / genetics*
  • Trinucleotide Repeats / genetics*

Substances

  • HLA-B27 Antigen
  • Histocompatibility Antigens Class I
  • MHC class I-related chain A

Grants and funding